Pulmonary vascular remodeling has now been described through various mechanisms in PAH; Not only proliferation of PAECs and PASMCs, but also abnormal increases in the production of growth factors such as vascular endothelial growth factor (VEGF) and PDGF. The gene discussed is VEGFA; the disease is pulmonary arterial hypertension.